|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Millenium Pharmacon International Tbk, PT
Main Activities: Merchant Wholesalers, Durable Goods - Merchant Wholesalers, Nondurable Goods
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Millenium Pharmacon International Tbk, PT Headquarters 9/F Gedung Bank Panin Center Jln Jend Sudirman - Senayan; Jakarta; Jakarta; 10270 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : ID1000072804 Financial Auditors: Tjahjadi & Tamara (2011) Incorporation Date: October 20, 1952 Total Employees: 807 Tel: (62 21) 72788907 |
|
Company Description |
| PT Millenium Pharmacon International Tbk (SDPC), formerly PT. NVPD Soedarpo Corporation Tbk, is engaged in activities relating to distribution of pharmaceuticals, nutritional and consumer goods. SDPC also provides medical supplies (prescription and non-prescription) and medical equipment to government institutions. The principals such as PT. Merck Tbk, PT. Meiji Indonesia, PT. Guardian Pharmatama Indonesia, trust its products to be distributed comprising national principal or multi national principal, | ||
|
||
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues increased with 22.25%, from IDR 710,996,992 thousands to IDR 869,165,122 thousands. Operating result increased from IDR 10,338,421 thousands to IDR 16,299,067 thousands which means 57.66% change. The results of the period increased 176.31% reaching IDR 6,882,816 thousands at the end of the period against IDR 2,490,977 thousands last year. Return on equity (Net income/Total equity) went from 2.67% to 6.77%, the Return On Asset (Net income / Total Asset) went from 0.80% to 1.84% and the Net Profit Margin (Net Income/Net Sales) went from 0.35% to 0.79% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 268.19% compared to 233.65% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.38 to 1.36 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Y (cons) |
2012 Q3C (cons) |
|
 | ||
| Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
385,609,728 |
374,300,352 |
| ||
Current Assets |
364,968,160 |
352,348,512 |
| ||
Total Liabilities |
280,984,832 |
272,640,896 |
| ||
Shareholders Equity |
104,624,888 |
101,659,480 |
| ||
Current Liabilities |
266,856,400 |
259,207,824 |
| ||
| * All the accounts are in IDR. | ||
Income Statement
| ||
Total Operating Revenue |
1,173,599,725 |
869,165,122 |
| ||
Operational Profit (Loss) |
22,936,680 |
16,299,067 |
| ||
Net Profit (Loss) |
9,848,224 |
6,882,816 |
| ||
| * All the accounts are in IDR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
2.55% |
1.84% |
| ||
Annualised Return on Assets (ROA) |
2.55% |
2.45% |
| ||
Return on Equity (ROE) |
9.41% |
6.77% |
| ||
Annualised Return on Equity (ROE) |
9.41% |
9.03% |
| ||
Return on Sales (ROS) |
0.84% |
0.79% |
| ||
Return on Capital |
9.41% |
6.77% |
| ||
Gross Profit Margin |
8.91% |
8.91% |
| ||
Operating Profit Margin |
2.34% |
2.35% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
6.66x |
5.03x |
| ||
Inventory Turnover |
7.63x |
6.02x |
| ||
Current asset turnover |
3.21x |
2.47x |
| ||
Fixed-asset turnover |
56.83x |
39.59x |
| ||
Asset Turnover |
3.04x |
2.32x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
24,667,744 |
17,929,785 |
| ||
EBITDA |
28,091,613 |
20,464,930 |
| ||
Enterprise value |
154,285,072 |
150,822,428 |
| ||
Enterprise Value / EBITDA |
5.49 |
7.37 |
| ||
Bookvalue (BV) |
270,803,832 |
257,767,280 |
| ||
Net Cash |
-239,359,576 |
-230,889,180 |
| Liquidity Ratios | ||
| ||
Current Ratio |
136.77% |
135.93% |
| ||
Quick ratio |
84.3% |
85.19% |
| ||
Doom's day ratio |
10.3% |
10.93% |
| Leverage Ratios | ||
| ||
Leverage ratio |
368.56% |
368.19% |
| ||
Interest Coverage Ratio |
247.17% |
241.72% |
| ||
Debt to equity |
268.56% |
268.19% |
| ||
Debt to total assets |
72.87% |
72.84% |
| ||
Long Term Debt to Capital |
16.25% |
15.58% |
| ||
Debt / Enterprise Value |
74.41% |
77.27% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
2.38 |
3.06 |
| ||
Price/Book Ratio |
0.25 |
0.24 |
| ||
Market Cap / Net cash |
-0.28 |
-0.27 |
| Trend Ratios | ||
| ||
Revenue Trend |
120.53% |
122.23% |
| ||
Net Income Trend |
246.11% |
276.31% |
| ||
Operating Income Trend |
132.17% |
153.96% |
| ||
 |